evidencegaps
Primary study · included by 1 review

Orabona 2022

Included by

Platelet-rich fibrin as a therapeutic modality for oroantral communication closure: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Orabona 2022 · References 12-30; Figure 2
Outcome this study informsPooled effectEvidenceCertainty
Successful closure of oroantral communication/fistula
Platelet-rich fibrin (PRF) closure vs Alternative therapeutics (buccal advancement flap, oral wound dressing/gauze, 3D printed mesh) · Follow-up as reported by included studies (closure typically by 3 weeks)
RR 1.00 [0.90, 1.04]6 studies · 296 participantsGRADE not reported

1 including review in total.